Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?

por Kaufman-Janette, Joely, Cox, Sue Ellen, Dayan, Steven, Joseph, John
Publicado 2021

The Psychological Impacts of Upper Facial Lines: A Qualitative, Patient-Centered Study

por Dayan, Steven, Yoelin, Steven G, De Boulle, Koenraad, Garcia, Julie K
Publicado 2019

Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines: Results from Two Multicenter, Randomized, Controlled Trials

por Baumann, Leslie, Dayan, Steven, Connolly, Simon, Silverberg, Nancy, Lei, Xiaofang, Drinkwater, Adrienne, Gallagher, Conor J.
Publicado 2016

Safe and Effective Chin Augmentation With the Hyaluronic Acid Injectable Filler, VYC-20L

por Beer, Kenneth, Kaufman-Janette, Joely, Bank, David, Biesman, Brian, Dayan, Steven, Kim, William, Chawla, Smita, Schumacher, Andrew
Publicado 2021

High-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice

por Fabi, Sabrina Guillen, Carruthers, Jean, Joseph, John, Cox, Sue Ellen, Yoelin, Steve, Few, Julius, Kaufman-Janette, Joely, Dayan, Steven
Publicado 2021

Facial Aesthetic Priorities and Concerns: A Physician and Patient Perception Global Survey

por Fabi, Sabrina, Alexiades, Macrene, Chatrath, Vandana, Colucci, Ligia, Sherber, Noëlle, Heydenrych, Izolda, Jagdeo, Jared, Dayan, Steven, Swift, Arthur, Chantrey, Jonquille, Stevens, W Grant, Sangha, Sara
Publicado 2021

Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines

por Dayan, Steven, Joseph, John, Moradi, Amir, Lorenc, Z. Paul, Coleman, Kyle, Ablon, Glynis, Kaufman‐Janette, Joely, Cox, Sue Ellen, Campbell, Andrew, Munavalli, Girish, Prygova, Inna
Publicado 2022

Multimodal Facial Aesthetic Treatment on the Appearance of Aging, Social Confidence, and Psychological Well-being: HARMONY Study

por Cohen, Joel L, Rivkin, Alexander, Dayan, Steven, Shamban, Ava, Werschler, W Philip, Teller, Craig F, Kaminer, Michael S, Sykes, Jonathan M, Weinkle, Susan H, Garcia, Julie K
Publicado 2021

Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials

por Dayan, Steven H, Schlessinger, Joel, Beer, Kenneth, Donofrio, Lisa M, Jones, Derek H, Humphrey, Shannon, Carruthers, Jean, Lizzul, Paul F, Gross, Todd M, Beddingfield, Frederick C, Somogyi, Christine
Publicado 2018

Efficacy and Safety of Tapencarium (RZL-012) in Submental Fat Reduction

por Shridharani, Sachin M, Dayan, Steven, Biesman, Brian, Cohen, Joel, Downie, Jeanine, Jones, Derek, Shamban, Ava, Fabi, Sabrina, Yoelin, Steve, Fagien, Steven, Ablon, Glynis, Gold, Michael, Gueta, Racheli, Walker, Patricia
Publicado 2023

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Pat...

por Lorenc, Z Paul, Adelglass, Jeffrey M, Avelar, Rui L, Baumann, Leslie, Beer, Kenneth R, Cohen, Joel L, Cox, Sue Ellen, Dayan, Steven H, Dover, Jeffrey S, Downie, Jeanine B, Draelos, Zoe Diana, Goldman, Mitchel P, Gross, John E, Joseph, John H, Kaufman-Janette, Joely, Moy, Ronald L, Nestor, Mark, Schlessinger, Joel, Smith, Stacy R, Weiss, Robert A
Publicado 2021

Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Li...

por Lorenc, Z Paul, Adelglass, Jeffrey M, Avelar, Rui L, Baumann, Leslie, Beer, Kenneth R, Cohen, Joel L, Cox, Sue Ellen, Dayan, Steven H, Dover, Jeffrey S, Downie, Jeanine B, Draelos, Zoe Diana, Goldman, Mitchel P, Gross, John E, Joseph, John H, Kaufman-Janette, Joely, Moy, Ronald L, Nestor, Mark, Schlessinger, Joel, Smith, Stacy R, Weiss, Robert A
Publicado 2021